Adalimumab (a fully human anti-tumour necrosis factor   monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials

R Rau

doi:10.1136/ard.61.suppl_2.ii70

Adalimumab (a fully human anti-tumour necrosis factor monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials

Annals of the Rheumatic Diseases ◽

10.1136/ard.61.suppl_2.ii70 ◽

2002 ◽

Vol 61 (Supplement 2) ◽

pp. 70ii-73 ◽

Cited By ~ 80

Author(s):

R Rau

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Initial Results ◽

Necrosis Factor

Download Full-text

FRI0060 Successful treatment of active rheumatoid arthritis with chimeric monoclonal antibody to tumour necrosis factor (infliximab): an open study

10.1136/annrheumdis-2001.1189 ◽

2001 ◽

Author(s):

KA Boki ◽

VA Vassiliou ◽

G Linardaki ◽

HM Moutsopoulos

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumour Necrosis Factor ◽

Successful Treatment ◽

Open Study ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Chimeric Monoclonal Antibody ◽

Necrosis Factor

Download Full-text

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

The Lancet ◽

10.1016/s0140-6736(94)90628-9 ◽

1994 ◽

Vol 344 (8930) ◽

pp. 1105-1110 ◽

Cited By ~ 1098

Author(s):

M.J Elliott ◽

R.N Maini ◽

M Feldmann ◽

J.R Kalden ◽

C Antoni ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Α ◽

Double Blind ◽

Chimeric Monoclonal Antibody ◽

Blind Comparison ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

The Lancet ◽

10.1016/s0140-6736(12)61424-x ◽

2013 ◽

Vol 381 (9865) ◽

pp. 451-460 ◽

Cited By ~ 393

Author(s):

Gerd R Burmester ◽

Ricardo Blanco ◽

Christina Charles-Schoeman ◽

Jürgen Wollenhaupt ◽

Cristiano Zerbini ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2011-200956 ◽

2012 ◽

Vol 71 (10) ◽

pp. 1671-1679 ◽

Cited By ~ 38

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Robert B M Landewé ◽

Eric L Matteson ◽

Norman Gaylis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Previous Experience ◽

Double Blind ◽

Double Blind Placebo ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy

Annals of the Rheumatic Diseases ◽

10.1136/ard.2006.066605 ◽

2007 ◽

Vol 66 (10) ◽

pp. 1284-1288 ◽

Cited By ~ 67

Author(s):

J. Grisar ◽

D. Aletaha ◽

C. W Steiner ◽

T. Kapral ◽

S. Steiner ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Progenitor Cells ◽

Endothelial Progenitor Cells ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Glucocorticoid Therapy ◽

Endothelial Progenitor ◽

Necrosis Factor

Download Full-text

Tumour necrosis factor blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study

Annals of the Rheumatic Diseases ◽

10.1136/ard.2009.119412 ◽

2009 ◽

Vol 69 (7) ◽

pp. 1281-1285 ◽

Cited By ~ 43

Author(s):

M. J. L. Peters ◽

P. Welsh ◽

I. B. McInnes ◽

G. Wolbink ◽

B. A. C. Dijkmans ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Brain Natriuretic Peptide ◽

Tumour Necrosis Factor ◽

Natriuretic Peptide ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Necrosis Factor

Download Full-text

Efficacy and safety of the fully human anti-tumour necrosis factor monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Annals of the Rheumatic Diseases ◽

10.1136/ard.2003.009563 ◽

2003 ◽

Vol 62 (12) ◽

pp. 1168-1177 ◽

Cited By ~ 110

Author(s):

L B A van de Putte

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumour Necrosis Factor ◽

Phase Ii ◽

Tumour Necrosis ◽

Phase Ii Study ◽

Efficacy And Safety ◽

Necrosis Factor

Download Full-text

Randomised double blind trial of safety of anti-tumour necrosis factor (anti-TNF) chimeric monoclonal antibody (infliximab) in combination with methatrexate compared to methatrexate alone in patients with rheumatoid arthritis on standard disease modifying anti-rheumatic drugs

http://isrctn.org/> ◽

10.1186/isrctn51200229 ◽

2013 ◽

Author(s):

Simon Till

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Chimeric Monoclonal Antibody ◽

Disease Modifying ◽

Necrosis Factor

Download Full-text

Effects of tumour necrosis factor alpha blockade on lipid profile in active rheumatoid arthritis

Rheumatology ◽

10.1093/rheumatology/kem195 ◽

2007 ◽

Vol 46 (10) ◽

pp. 1626-1627 ◽

Cited By ~ 6

Author(s):

F. Del Porto ◽

B. Lagana ◽

I. Nofroni ◽

F. Tinti ◽

A. P. Mitterhofer ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Lipid Profile ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Alpha Blockade ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1841 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A619.3-A620 ◽

Cited By ~ 1

Author(s):

M. C. Vieira ◽

G. Wallenstein ◽

J. Bradley ◽

D. Gruben ◽

T. Koncz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text